| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.43 | 0.02 |